Invitrogen™ Peptide synthétique SYPL2 humain
Synthetic Peptide
- Gene ID (Entrez)
- 284612
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- Q5VXT5
- Nom usuel
- Human SYPL2
- Marque
- Invitrogen
"/>
Synthetic Peptide
SYPL2 Synthetic Peptide, PEP-0890, from Invitrogen.
SYPL2, also known as Mitsugumin 29, was initially identified as a transmembrane protein from the triad junction in skeletal muscle that had significant homology with members of the synaptophysin family. SYPL2 is thought to participate in the excitation-contraction coupling process of skeletal muscle as SYPL2-null mice showed reduced muscle contractile force and altered triad junction structure and increased susceptibility to fatigue of the skeletal muscle. SYPL2 plays a critical role in muscle Ca2+ signaling by regulating the process of store-operated Ca2+ entry and interacts with ryanodine receptor (RyR), thereby influencing intracellular Ca2+ homeostasis through changes in the RyR/Ca2+ release function. Co-expression of SYPL2 and RyR in cultured cells leads to apoptotic cell death resulting from the depletion of Ca2+ from the intracellular stores.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-177105 |
| Réf. fabricant | 15349130 |
| Gene ID (Entrez) | 284612 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q5VXT5 |
| Nom usuel | Human SYPL2 |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | SYPL2 |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |